Nimesulide

Nimesulide

SCHEMBL24882

CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 18/20 1.00
MEN1 O00255 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
MAPT P10636 2/20 1.00
TSHR P16473 2/20 1.00
PTGS1 P23219 2/20 1.00
PTGS2 P35354 2/20 1.00
KMT2A Q03164 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
KDM4E B2RXH2 1/20 1.00
MLNR O43193 1/20 1.00
LMNA P02545 1/20 1.00
MMP1 P03956 1/20 1.00
MPO P05164 1/20 1.00
GLA P06280 1/20 1.00
ADORA3 P0DMS8 1/20 1.00
CYP2C9 P11712 1/20 1.00
HPGD P15428 1/20 1.00
TBXA2R P21731 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nimesulide SCHEMBL29393272 1.00 CYP19A1 (1.00) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL4796058 1.00 CYP19A1 (1.00) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL3120335 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL3367702 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL11790433 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL25233223 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL3367706 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL10381405 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL29106069 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT
Nimesulide SCHEMBL3120339 0.99 CYP19A1 (0.97) CYP19A1MEN1CYP1A2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3841097-B1 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) 2026-05-20 EP claimed
EP-4744663-A2 SKIN COMPOSITION Eaderm Co., Ltd. (JP) 2026-05-20 EP claimed
EP-4745155-A1 POWDER CONTAINING PARTICLES OF GELATIN DERIVATIVE AND APPLICATION OF SAME IN MEDICAL TREATMENT National Institute for Materials Science (JP) 2026-05-20 EP claimed
US-20260130928-A1 COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN ASCENTAWITS PHARMACEUTICALS LTD (CN) 2026-05-14 US claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
US-20260115205-A1 ON DEMAND FEMALE CONTRACEPTIVE ARCHER DAVID FITZGERALD (US) 2026-04-30 US claimed
US-12605432-B2 Combinations for antigen based therapy DIAMYD MEDICAL AB (SE) 2026-04-21 US claimed
US-20260069532-A1 METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE MEDINCELL S.A. (FR) 2026-03-12 US claimed
US-12558309-B2 Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue MEDINCELL S.A. (FR) 2026-02-24 US claimed
US-20260048013-A1 PHARMACEUTICAL FORMULATION WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY CONSEJO SUPERIOR INVESTIGACION (ES) 2026-02-19 US claimed
EP-0282380-A1 Compositions for the treatment of wood and processes for the treatment of wood RHONE-POULENC CHIMIE (FR) 1988-09-14 EP claimed
EP-0277768-A2 Laser having a substantially planar waveguide AMOCO CORPORATION (US) 1988-08-10 EP claimed
EP-0153212-B1 4,4-DIMETHYL TETRAHYDRO-2H-PYRAN-2-ON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF CYCLOPROPANIC DERIVATIVES ROUSSEL-UCLAF (FR) 1988-07-13 EP claimed
WO-1988003044-A1 METHOD FOR THE CONCENTRATION AND SEPARATION OF ACTINIDES FROM BIOLOGICAL AND ENVIRONMENTAL SAMPLES ARCH DEVELOPMENT CORP. (US) 1988-05-05 WO claimed
EP-0262395-A2 Sulfonamido-ethyl compounds, medicines containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1988-04-06 EP claimed
EP-0261408-A2 Laser including monolithically integrated planar devices and processes for their preparation EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-03-30 EP claimed
EP-0260476-A2 Monolithically integrated planar lasers differing in emission wavelengths and processes for their preparation EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-03-23 EP claimed
EP-0260475-A2 A process for forming a positive index waveguide EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-03-23 EP claimed
EP-0255246-A2 Image pick-up tube HITACHI, LTD. (JP) 1988-02-03 EP claimed
EP-0218154-A2 Tri-nickel aluminide compositions ductile at hot-short temperatures GENERAL ELECTRIC COMPANY (US) 1987-04-15 EP claimed